Main > ONCOLOGY (**) > Breast Cancer>HR+>HER2->MET>PM * > SE. B. Progression Monitoring TKa A
id
SE. B. Progression Monitoring TKa A's subsections
(*) USA Approval Date: 2022. 07.30
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2022. 08.02
RTM
RTM Web-Site
TKa: Thymidine Kinase activity
SE. B. Progression Monitoring TKa A's products
This section has no products